Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Identification and Characterization of Chemical Compounds that Inhibit Leucyl-tRNA Synthetase from Pseudomonas aeruginosa

Author(s): Regina Zamacona, Pamela N. Chavero, Eduardo Medellin, Yanmei Hu, Casey A. Hughes, Nathalie Quach, Megan Keniry and James M. Bullard*

Volume 17, Issue 1, 2020

Page: [119 - 130] Pages: 12

DOI: 10.2174/1570163815666180808095600

Price: $65

Abstract

Background: Pseudomonas aeruginosa is an opportunistic multi-drug resistance pathogen implicated as the causative agent in a high-percentage of nosocomial and community acquired bacterial infections. The gene encoding leucyl-tRNA synthetase (LeuRS) from P. aeruginosa was overexpressed in Escherichia coli and the resulting protein was characterized.

Methods: LeuRS was kinetically evaluated and the KM values for interactions with leucine, ATP and tRNA were 6.5, 330, and 3.0 μM, respectively. LeuRS was developed into a screening platform using scintillation proximity assay (SPA) technology and used to screen over 2000 synthetic and natural chemical compounds.

Results: The initial screen resulted in the identification of two inhibitory compounds, BT03C09 and BT03E07. IC50s against LeuRS observed for BT03C09 and BT03E07 were 23 and 15 μM, respectively. The minimum inhibitory concentrations (MIC) were determined against nine clinically relevant bacterial strains. In time-kill kinetic analysis, BT03C09 was observed to inhibit bacterial growth in a bacteriostatic manner, while BT03E07 acted as a bactericidal agent. Neither compound competed with leucine or ATP for binding LeuRS. Limited inhibition was observed in aminoacylation assays with the human mitochondrial form of LeuRS, however when tested in cultures of human cell line, BT03C09 was toxic at all concentration whereas BT03E07 only showed toxic effects at elevated concentrations.

Conclusion: Two compounds were identified as inhibitors of LeuRS in a screen of over 2000 natural and synthetic compounds. After characterization one compound (BT03E07) exhibited broad spectrum antibacterial activity while maintaining low toxicity against human mitochondrial LeuRS as well as against human cell cultures.

Keywords: leucyl-tRNA synthetase, protein synthesis, Pseudomonas aeruginosa, drug discovery, antibiotics, E. coli.

Graphical Abstract

[1]
Giamarellou H, Kanellakopoulou K. Current therapies for pseudomonas aeruginosa. Crit Care Clin 2008; 24(2): 261-78, viii.
[http://dx.doi.org/10.1016/j.ccc.2007.12.004] [PMID: 18361945]
[2]
Breidenstein EB, de la Fuente-Núñez C, Hancock RE. Pseudomonas aeruginosa: All roads lead to resistance. Trends Microbiol 2011; 19(8): 419-26.
[http://dx.doi.org/10.1016/j.tim.2011.04.005] [PMID: 21664819]
[3]
Eriani G, Delarue M, Poch O, Gangloff J, Moras D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature 1990; 347(6289): 203-6.
[http://dx.doi.org/10.1038/347203a0] [PMID: 2203971]
[4]
Jakubowski H. Quality control in tRNA charging. Wiley Interdiscip Rev RNA 2012; 3(3): 295-310.
[http://dx.doi.org/10.1002/wrna.122] [PMID: 22095844]
[5]
Crepin T, Schmitt E, Mechulam Y, et al. Use of analogues of methionine and methionyl adenylate to sample conformational changes during catalysis in Escherichia coli methionyl-tRNA synthetase. J Mol Biol 2003; 332(1): 59-72.
[http://dx.doi.org/10.1016/S0022-2836(03)00917-3] [PMID: 12946347]
[6]
Cavarelli J, Delagoutte B, Eriani G, Gangloff J, Moras D. L-arginine recognition by yeast arginyl-tRNA synthetase. EMBO J 1998; 17(18): 5438-48.
[http://dx.doi.org/10.1093/emboj/17.18.5438] [PMID: 9736621]
[7]
Newberry KJ, Hou YM, Perona JJ. Structural origins of amino acid selection without editing by cysteinyl-tRNA synthetase. EMBO J 2002; 21(11): 2778-87.
[http://dx.doi.org/10.1093/emboj/21.11.2778] [PMID: 12032090]
[8]
Asahara H, Himeno H, Tamura K, Hasegawa T, Watanabe K, Shimizu M. Recognition nucleotides of Escherichia coli tRNA(Leu) and its elements facilitating discrimination from tRNASer and tRNA(Tyr). J Mol Biol 1993; 231(2): 219-29.
[http://dx.doi.org/10.1006/jmbi.1993.1277] [PMID: 8510145]
[9]
Hu Y, Guerrero E, Keniry M, Manrrique J, Bullard JM. Identification of chemical compounds that inhibit the function of glutamyl-tRNA synthetase from Pseudomonas aeruginosa. J Biomol Screen 2015; 20(9): 1160-70.
[http://dx.doi.org/10.1177/1087057115591120] [PMID: 26116192]
[10]
Corona A, Palmer SO, Zamacona R, Mendez B, Dean FB, Bullard JM. Discovery and characterization of chemical compounds that inhibit the function of aspartyl-tRNA synthetase from Pseudomonas aeruginosa. SLAS Discov 2018; 23(3): 294-301.
[http://dx.doi.org/10.1177/2472555217744559] [PMID: 29186665]
[11]
Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: Approved guidelines M7-A7 CLSI, Wayne PA M7-A7. Clinical and Laboratory Standards Institute 2006
[12]
Ribble W, Hill WE, Ochsner UA, et al. Discovery and analysis of 4H-pyridopyrimidines, a class of selective bacterial protein synthesis inhibitors. Antimicrob Agents Chemother 2010; 54(11): 4648-57.
[http://dx.doi.org/10.1128/AAC.00638-10] [PMID: 20696870]
[13]
Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A CLSI, Wayne, PA M26-A. Clinical and Laboratory Standards Institute 2002
[14]
Bullard JM, Cai YC, Spremulli LL. Expression and characterization of the human mitochondrial leucyl-tRNA synthetase. Biochim Biophys Acta 2000; 1490(3): 245-58.
[http://dx.doi.org/10.1016/S0167-4781(99)00240-7] [PMID: 10684970]
[15]
Hu Y, Keniry M, Palmer SO, Bullard JM. Discovery and analysis of natural product compounds inhibiting protein synthesis in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2016; 60(8): 4820-9.
[http://dx.doi.org/10.1128/AAC.00800-16] [PMID: 27246774]
[16]
Palencia A, Crépin T, Vu MT, Lincecum TL Jr, Martinis SA, Cusack S. Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetase. Nat Struct Mol Biol 2012; 19(7): 677-84.
[http://dx.doi.org/10.1038/nsmb.2317] [PMID: 22683997]
[17]
Tukalo M, Yaremchuk A, Fukunaga R, Yokoyama S, Cusack S. The crystal structure of leucyl-tRNA synthetase complexed with tRNALeu in the post-transfer-editing conformation. Nat Struct Mol Biol 2005; 12(10): 923-30.
[http://dx.doi.org/10.1038/nsmb986] [PMID: 16155583]
[18]
Cusack S, Yaremchuk A, Tukalo M. The 2 A crystal structure of leucyl-tRNA synthetase and its complex with a leucyl-adenylate analogue. EMBO J 2000; 19(10): 2351-61.
[http://dx.doi.org/10.1093/emboj/19.10.2351] [PMID: 10811626]
[19]
Fukunaga R, Yokoyama S. Aminoacylation complex structures of leucyl-tRNA synthetase and tRNALeu reveal two modes of discriminator-base recognition. Nat Struct Mol Biol 2005; 12(10): 915-22.
[http://dx.doi.org/10.1038/nsmb985] [PMID: 16155584]
[20]
Kumar M, Kumar SA, Dimkovikj A, et al. Zinc is the molecular “switch” that controls the catalytic cycle of bacterial leucyl-tRNA synthetase. J Inorg Biochem 2015; 142: 59-67.
[http://dx.doi.org/10.1016/j.jinorgbio.2014.09.006] [PMID: 25450019]
[21]
Chen JF, Guo NN, Li T, Wang ED, Wang YL. CP1 domain in Escherichia coli leucyl-tRNA synthetase is crucial for its editing function. Biochemistry 2000; 39(22): 6726-31.
[http://dx.doi.org/10.1021/bi000108r] [PMID: 10828991]
[22]
Schnier JB, Gadbois DM, Nishi K, Bradbury EM. The kinase inhibitor staurosporine induces G1 arrest at two points: effect on retinoblastoma protein phosphorylation and cyclin-dependent kinase 2 in normal and transformed cells. Cancer Res 1994; 54(22): 5959-63.
[PMID: 7954429]
[23]
Antimicrobial Drug Resistance. Report by the Secretariat A67/39, 1-5. Geneva, Switzerland: World Health Organization 2014.
[24]
Hernandez V, Crépin T, Palencia A, et al. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Antimicrob Agents Chemother 2013; 57(3): 1394-403.
[http://dx.doi.org/10.1128/AAC.02058-12] [PMID: 23295920]
[25]
Monteferrante CG, Jirgensons A, Varik V, Hauryliuk V, Goessens WH, Hays JP. Evaluation of the characteristics of leucyl-tRNA synthetase (LeuRS) inhibitor AN3365 in combination with different antibiotic classes. Eur J Clin Microbiol Infect Dis 2016; 35(11): 1857-64.
[http://dx.doi.org/10.1007/s10096-016-2738-1] [PMID: 27506217]
[26]
Gudzera OI, Golub AG, Bdzhola VG, et al. Identification of Mycobacterium tuberculosis leucyl-tRNA synthetase (LeuRS) inhibitors among the derivatives of 5-phenylamino-2H- [1,2,4]triazin-3-one. J Enzyme Inhib Med Chem 2016; 31(sup2): 201-7.
[http://dx.doi.org/10.1080/14756366.2016.1190712] [PMID: 27241561]
[27]
Martinis SA, Plateau P, Cavarelli J, Florentz C. Aminoacyl-tRNA synthetases: a new image for a classical family. Biochimie 1999; 81(7): 683-700.
[http://dx.doi.org/10.1016/S0300-9084(99)80126-6] [PMID: 10492015]
[28]
Yao P, Poruri K, Martinis SA, Fox PL. Non-catalytic regulation of gene expression by aminoacyl-tRNA synthetases. Top Curr Chem 2014; 344: 167-87.
[http://dx.doi.org/10.1007/128_2013_422] [PMID: 23536244]
[29]
Hornig-Do HT, Montanari A, Rozanska A, et al. Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations. EMBO Mol Med 2014; 6(2): 183-93.
[http://dx.doi.org/10.1002/emmm.201303202] [PMID: 24413189]
[30]
Inoue K, Kumakura S, Uchida M, Tsutsui T. Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. J Periodontal Res 2004; 39(1): 50-8.
[http://dx.doi.org/10.1111/j.1600-0765.2004.00704.x] [PMID: 14687228]

Rights & Permissions Print Cite
Article Metrics
8
© 2024 Bentham Science Publishers | Privacy Policy